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Accumulation of Metabolic Cardiovascular Risk Factors in Black and
White Young Adults Over 20 Years
Nina P. Paynter, PhD, MHS; Catarina I. Kiefe, PhD, MD; Cora E. Lewis, MD, MSPH; Catherine M. Loria, PhD, MS; David C. Goff, Jr, MD, PhD;
Donald M. Lloyd-Jones, MD, ScM
Background-—Cross-sectional clustering of metabolic risk factors for cardiovascular disease in middle-aged adults is well
described, but less is known regarding the order in which risk factors develop through young adulthood and their relation to
subclinical atherosclerosis.
Method and Results-—A total of 3178 black and white women and men in the Coronary Artery Risk Development in Young Adults
study were assessed to identify the order in which cardiovascular disease risk factors including diabetes, hypertension,
dyslipidemia (low high-density lipoprotein cholesterol or high triglyceride levels), hypercholesterolemia (high total or low-density
lipoprotein cholesterol), and obesity develop. Observed patterns of risk factor development were compared with those expected if
risk factors accumulated randomly, given their overall distribution in the population. Over the 20 years of follow-up, 80% of
participants developed at least 1 risk factor. The ﬁrst factor to occur was dyslipidemia in 39% of participants, obesity in 20%,
hypercholesterolemia in 11%, hypertension in 7%, and diabetes in 1%. Dyslipidemia was the only risk factor both to occur ﬁrst and
to be followed by additional risk factors more often than expected (P<0.001 for both). Order of risk factor accrual did not affect
subclinical atherosclerosis at year 20. Results were similar by sex, race, and smoking status.
Conclusions-—Multiple patterns of cardiovascular risk factor development were observed from young adulthood to middle age.
Dyslipidemia, a potentially modiﬁable condition, often preceded the development of other risk factors and may be a useful target
for intervention and monitoring. ( J Am Heart Assoc. 2015;4:e001548 doi: 10.1161/JAHA.114.001548)
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C ardiovascular risk factors have been observed to clusterin youth,1,2 young adulthood,3 and middle age,4 and the
presence of additional risk factors has been shown to
increase risk of subclinical atherosclerosis development in
young and middle-aged adults5,6 and risk of clinical cardio-
vascular disease in middle age.4 It is not clear, however, which
risk factors appear ﬁrst and which are potentially early
markers of subsequent additional risk, especially in the
window between young adulthood and middle age.
Similarly, multiple studies have examined the subset of risk
factors known as the metabolic syndrome; these risk factors
have been observed to cluster together consistently over
time,7 but less is known about accrual order. Recent data
have suggested that the order of accumulation in middle age
is associated with clinical outcomes.8 Interrelations between
pairs of cardiovascular risk factors have also been studied
extensively. Weight gain has been shown to be associated
with changes in lipids, increases in fasting glucose, and
increases in blood pressure in young adults.9 Hypertension
has been associated with incident diabetes,10 and insulin
resistance has been associated with incident hypertension.11
Other studies have observed an increase in incident diabe-
tes12 and incident hypertension13 following abnormal lipid
levels.
This study aimed to identify patterns in the accrual of
major metabolic cardiovascular risk factors in black and white
women and men throughout young adulthood to middle age
and to examine the relationship of these patterns with
subclinical atherosclerosis. We used data from the Coronary
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Artery Risk Development in Young Adults (CARDIA) study,
which included 20 years of follow-up, to measure and
examine patterns of cardiovascular risk factor accrual overall
and by race, sex, and smoking status.
Methods
Study Population
The CARDIA study enrolled 5115 black and white women and
men from 4 US sites.14 Baseline (1985–1986) recruitment
procedures were designed to balance age, sex, ethnicity, and
education groups within each of 3 US communities studied
(Birmingham, Alabama; Minneapolis, Minnesota; and Chicago,
Illinois) and a health insurance company based in Oakland,
California. Participants were aged 18 to 30 years at baseline
and were followed up for 20 years, with examinations at
baseline (year 0) and at years 2, 5, 7, 10, 15, and 20, with a
retention rate of 72% of the surviving cohort at year 20. All
participants provided informed consent at each examination,
and all study protocols were approved by the institutional
review board at each center. We excluded participants for
whom complete risk factor information was not available at
the year 20 examination (1935 participants) and excluded
those who had all 5 metabolic risk factors at baseline (1
participant), leaving 3178 participants.
Risk Factors
We focused on 5 metabolic risk factors for cardiovascular
disease: hypertension, hypercholesterolemia, dyslipidemia,
diabetes, and obesity. Blood pressure was measured 3 times
at each examination, according to previously published
protocols.14 The average systolic and diastolic pressures
from the last 2 measurements were used. Participants were
classiﬁed as having hypertension at the ﬁrst visit at which
they had elevated blood pressure (≥140 mm Hg systolic or
≥90 mm Hg diastolic) or reported use of antihypertensive
medication.
Total cholesterol, low-density lipoprotein cholesterol, tri-
glycerides, and high-density lipoprotein cholesterol (HDL-C)
were measured at each visit from a fasting blood sample
processed at a central laboratory.14,15 Participants were
classiﬁed as having hypercholesterolemia at the ﬁrst visit at
which total cholesterol was ≥240 mg/dL, low-density lipo-
protein cholesterol was >160 mg/dL, or use of cholesterol-
lowering medications was reported (for years 5 through 20).16
Patients were classiﬁed as having dyslipidemia at the ﬁrst visit
at which HDL-C was <50 mg/dL in women or <40 mg/dL in
men or triglyceride levels were >200 mg/dL in either sex.
Blood glucose was measured from fasting blood samples at
baseline and at years 7, 10, 15, and 20.14 Patients were asked
at all visits about medication use and diagnosis of diabetes.
Participants were classiﬁed as having diabetes at the ﬁrst visit
with fasting blood glucose ≥126 mg/dL (when available),
reported use of diabetes medication, or reported physician
diagnosis of diabetes.
Weight, height, and waist circumference were also mea-
sured at each study visit, with participants wearing light
clothing, and body mass index was calculated as the weight in
kilograms divided by height in square meters. Participants
were classiﬁed as obese at the ﬁrst visit at which body mass
index was ≥30 or waist circumference was >88 cm in women
or >102 cm in men.
Information on smoking, including whether the participant
was currently smoking and the number of cigarettes smoked
per day, was collected at each study visit. In addition, prior
smoking information was collected at baseline. Using previ-
ously deﬁned methods for this cohort, cumulative exposure to
cigarettes in pack-years was calculated for each participant.17
Subclinical Cardiovascular Disease
Coronary artery calcium (CAC) was measured at year 20 using
computed tomography scanning with 2 scans for each
participant.18 All scans were analyzed by cardiovascular
radiologists blinded to participant characteristics, with high
within- and between-reader reliability. Summary Agatston
scores were calculated and dichotomized for this analysis into
any calciﬁcation (score >0) or no calciﬁcation (score 0).
Carotid intima-media thickness (CIMT) was measured at year
20 using the average of 4 ultrasound images measuring the
maximum thickness of the common carotid artery.19 A total of
2577 participants had information available on CAC and CIMT.
Statistical Methods
Risk factor accumulation was calculated by examining each
participant’s visit history. Visits were included if the status of all
risk factors could be determined and if the participant did not
report being pregnant at the time of the visit. Participants were
classiﬁed into groups according to the order in which risk
factors developed during follow-up. A participant who, for
example, ﬁrst developed obesity and then developed hyperten-
sion but no additional risk factors was placed in the obesity/
hypertension group. There were 326 possible groups: 120 with
5 risk factors, 120 with 4 risk factors, 60 with 3 risk factors, 20
with 2 risk factors, 5 with 1 risk factor, and 1 with none.
Weighted values corresponding to the probability of each
combination were used when the order of risk factor develop-
ment was unclear. A participant who had no risk factors at
baseline, hypertension at year 2 and dyslipidemia at year 7
would contribute full weighted value to the hypertension/
dyslipidemia group. A participant who had no risk factors at
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baseline and hypertension and dyslipidemia simultaneously at
year 2 would contribute 0.5 of their weighted value to each of
the hypertension/dyslipidemia and dyslipidemia/hypertension
groups.
The overall (or marginal) probability of developing each risk
factor over the 20-year follow-up period was calculated, and
these probabilities were used to obtain the expected joint
probabilities of each combination under the null hypothesis of
risk factor independence. Similarly, the expected probabilities
of combinations of risk factors and conditional probabilities
were also obtained.
These expected probabilities were then compared with the
observed rates for each question under examination. For
example, to examine whether hypertension or dyslipidemia
occurs ﬁrst when they are both present, we restricted our
analysis to the set of participants with hypertension and
dyslipidemia. Although dyslipidemia occurs more frequently
than hypertension in the population, within our restricted set,
both were equally likely to occur (with probability of 100%).
Under our null hypothesis, each factor has a uniform rate of
occurrence throughout the follow-up period, meaning that
hypertension or dyslipidemia could have occurred at any point
in the follow-up, and each were equally likely to have occurred
ﬁrst. We then compared the observed rate of hypertension
occurring ﬁrst to the expected rate of 50%. All observed and
expected probabilities were compared using a chi-square test
of proportions.
For participants with CIMT measures at year 20, we
generated expected CIMT values predicted by sex, race, age,
and smoking status at year 15 and pack-years smoked using a
linear model and subtracted these from the individual observed
values to obtain the residual CIMT for each participant. These
residuals were then combined using the weighting for each
sequence to obtain the mean residual for each accumulation
combination or conditional group. The mean residual for each
group was compared with the expected mean residual CIMT of
0. A similar process was followed for those participants with
measured CAC at year 20. We generated the expected
probability of any CAC predicted by sex, race age, and smoking
status and pack-years for each participant. Weighted average
expected probabilities were obtained for each group and
compared with the observed prevalence of CAC.
To further describe the associations within subgroups, we
performed the analyses stratiﬁed by race and sex categories
Table 1. Rates for Component Criteria for Cardiovascular
Risk Factors*
Indication n
Risk Factor
Identiﬁed
by Criteria, %
Diabetes
Nonfasting glucose >200 mg/dL 30 11
Fasting glucose ≥126 mg/dL 148 53
Diagnosis 54 19
Medication use 45 16
Dyslipidemia
Both high triglycerides and low HDL 99 5
HDL <40 mg/dL in men
or <50 mg/dL in women
1655 89
Triglycerides ≥200 mg/dL 103 6
Hypercholesterolemia
LDL ≥160 mg/dL 584 71
Total cholesterol ≥240 mg/dL 103 13
Medication use 134 16
Hypertension
Both high diastolic and systolic 150 17
Systolic blood pressure ≥140 mm Hg 87 10
Diastolic blood pressure ≥90 mm Hg 314 36
Medication use 331 38
Obesity
Both high BMI and WC 654 44
BMI ≥30, kg/m2 557 37
WC >102 cm in men
or >88 cm in women
278 19
BMI indicates body mass index; HDL, high-density lipoprotein; LDL, low-density
lipoprotein; WC, waist circumference.
*Criteria are assessed hierarchically in the order displayed (ie, once assigned to a
criterion, a participant is no longer evaluated for remaining criteria).
Table 2. Accumulation of Subsequent Metabolic Risk Factors When First Risk Factor Is Identiﬁed
First Risk Factor
Risk Factor Occurring
First, n (% of Total)
Observed With Subsequent Risk
Factor Accumulation, % (95% CI)
Expected With Subsequent
Risk Factor Accumulation, %
Ratio of Observed
to Expected
P Value for
Accumulation
DIAB 44 (1) 59 (44 to 73) 73 0.8 0.045
DYSL 1243 (39) 63 (60 to 65) 55 1.1 <0.001
HCL 363 (11) 71 (66 to 75) 70 1.0 0.74
HTN 233 (7) 56 (50 to 63) 70 0.8 <0.001
OBST 650 (20) 67 (63 to 70) 62 1.1 0.020
DIAB indicates diabetes; DYSL, dyslipidemia; HCL, hypercholesterolemia; HTN, hypertension; OBST, obesity.
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and by smoking status. We also performed an analysis using
the ATP III metabolic syndrome criteria,16 In this analysis, the
cutoffs were changed to ≥110 mg/dL for fasting glucose,
≥150 mg/dL for triglycerides, and ≥130 mm Hg for systolic
blood pressure.
All analyses were performed using R 2.10.0 (R Founda-
tion). A 2-tailed P value of <0.05 was considered statis-
tically signiﬁcant for each comparison in this analysis
because the results were meant to be hypothesis gener-
ating. The main results (Tables 2 through 4) include 30
comparisons in all, so a Bonferroni adjusted cutoff of
0.0017 could be used for those tables and would provide
similar results.
Results
Of the 3178 participants, 57% were female and 46% were
black. At baseline, the mean age was 25.1 years, with 25.6%
current smokers and 14.4% former smokers. This group was
more likely to be female, white, and nonsmokers than the
CARDIA cohort members who were not included (mean age
24.5 years, 51% female, 62% black, 13% former smokers, and
40% current smokers). After 20 years, 26.1% of participants
had hypertension, 25.8% had hypercholesterolemia, 55.4%
had dyslipidemia, 8.7% had diabetes, and 46.0% were obese.
More information on the deﬁnition of each risk factor is given
in Table 1. Of note, 89% of dyslipidemia was identiﬁed by low
HDL-C levels alone, and 5% had low HDL-C and elevated
triglycerides.
Risk Factor Accumulation
Of the 326 potential sequences of accumulation for the 5
risk factors, 280 were observed in our data. The sequence
in which no risk factors developed occurred 1.9 times as
often as expected, suggesting that risk factors clustered
rather than sorting independently. Among sequences with
at least 1 risk factor, when the association between a risk
factor occurring ﬁrst and subsequent risk factor accumu-
lation was examined (Table 2), we found that the probability
of accumulating at least 1 additional risk factor was
signiﬁcantly greater than expected for dyslipidemia and
obesity (1.1 times as much accumulation of other risk
factors observed versus expected for both). In contrast,
hypertension and diabetes occurring ﬁrst were followed by
an additional risk factor only 0.8 time as often as expected.
Accumulation following hypercholesterolemia did not occur
signiﬁcantly more or less than expected.
Risk Factor Order
We next looked at the order within sequences that had at
least 2 risk factors. The expected probability of a risk factor
Table 3. Distribution of First Risk Factors in Sequences With
at Least 2 Metabolic Risk Factors
Risk
Factor
Observed With
Risk Factor
First, % (95% CI)
Expected
With Risk
Factor
First, %
Ratio of
Observed
to Expected
P Value for Risk
Factor First
DIAB 10 (6 to 14) 39 0.3 <0.001
DYSL 56 (53 to 59) 43 1.3 <0.001
HCL 36 (32 to 40) 40 0.9 0.020
HTN 17 (14 to 19) 40 0.4 <0.001
OBST 34 (31 to 37) 42 0.8 <0.001
DIAB indicates diabetes; DYSL, dyslipidemia; HCL, hypercholesterolemia; HTN,
hypertension; OBST, obesity.
Table 4. Frequency and Order of Pairs of Metabolic Risk Factors
Pair
Observed With Pair,
n (95% CI) Expected, n
Ratio of Observed
to Expected P Value
Risk Factor More
Likely to be First
Observed as First,*
n (95% CI) P Value
DYSL and DIAB 213 (185 to 241) 514 0.4 <0.001 DYSL 86 (82 to 91) <0.001
DYSL and HCL 582 (539 to 625) 867 0.7 <0.001 DYSL 60 (56 to 64) <0.001
DYSL and HTN 610 (566 to 654) 153 4.0 <0.001 DYSL 80 (77 to 83) <0.001
DYSL and OBST 1081 (1029 to 1133) 471 2.3 <0.001 DYSL 64 (61 to 67) <0.001
HCL and DIAB 125 (104 to 146) 58 2.1 <0.001 HCL 60 (51 to 68) 0.040
HCL and HTN 327 (293 to 361) 223 1.5 <0.001 HCL 62 (57 to 67) <0.001
HCL and OBST 459 (420 to 498) 380 1.2 <0.001 OBST 51 (56 to 46) 0.71
HTN and DIAB 171 (146 to 196) 72 2.4 <0.001 HTN 57 (50 to 64) 0.08
OBST and DIAB 220 (192 to 248) 125 1.8 <0.001 OBST 85 (81 to 90) <0.001
OBST and HTN 601 (558 to 644) 412 1.5 <0.001 OBST 72 (69 to 76) <0.001
DIAB indicates diabetes; DYSL, dyslipidemia; HCL, hypercholesterolemia; HTN, hypertension; OBST, obesity.
*The percentage of observations with both risk factors for which the risk factor in the previous column appears ﬁrst.
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occurring ﬁrst depended only on the number of risk factors in
each sequence, for example, for all sequences of 3 risk
factors that include hypertension, hypertension should be ﬁrst
in one-third of them. As shown in Table 3, when dyslipidemia
was included in a sequence, it occurred ﬁrst 1.3 times more
often than expected. Conversely, diabetes occurred ﬁrst in a
sequence less often than expected (0.3 times as often as
expected), as did hypertension (0.4), obesity (0.8) and
hypercholesterolemia (0.9).
We also examined the occurrence of pairs of risk factors in
a sequence, which included sequences with only the pair of
risk factors and those with both the pair and additional risk
factors (Table 4). Most pairs occurred more often than
expected under random accrual, with the largest ratio of
observed to expected in dyslipidemia/hypertension (4.0 times
more often than expected); however, dyslipidemia/diabetes
and dyslipidemia/hypercholesterolemia occurred signiﬁcantly
less often than expected. When we examined the order in
which each pair occurred, dyslipidemia was more likely to
occur before any other risk factor. Hypercholesterolemia was
signiﬁcantly more likely to occur before diabetes and
hypertension; however, hypercholesterolemia and obesity
Table 5. Accumulation of Subsequent Metabolic Risk Factors by Subgroup When First Risk Factor is Identiﬁed
First Risk Factor Subgroup
Risk Factor
Occurring First
N (%)*
Percent Observed
With Accumulation
(95% CI)
Percent Expected
With Accumulation
Ratio of
Observed to
Expected
P Value for
Accumulation
Diabetes Never Smokers 26 (1) 57 (38, 76) 62 0.9 0.76
Ever Smokers 18 (1) 61 (39, 84) 67 0.9 0.81
Black Women 16 (<1) 74 (53, 96) 82 0.9 0.66
White Women 15 (<1) 32 (8, 56) 26 1.2 0.83
Black Men 7 (<1) 56 (19, 93) 38 1.5 0.58
White Men 6 (<1) 84 (56, 112) 53 1.6 0.22
Dyslipidemia Never Smokers 727 (23) 62 (58, 65) 55 1.1 <0.001
Ever Smokers 507 (16) 64 (59, 68) 54 1.2 <0.001
Black Women 334 (11) 77 (72, 81) 73 1.1 0.13
White Women 407 (13) 51 (47, 56) 39 1.3 <0.001
Black Men 156 (5) 64 (57, 72) 58 1.1 0.12
White Men 345 (11) 61 (56, 67) 50 1.2 <0.001
Hypercholesterolemia Never Smokers 221 (7) 69 (63, 75) 68 1.0 1.0
Ever Smokers 140 (4) 74 (66, 81) 70 1.0 0.46
Black Women 78 (2) 76 (66, 85) 84 0.9 0.054
White Women 76 (2) 63 (52, 74) 58 1.1 0.48
Black Men 86 (3) 75 (66, 85) 65 1.2 0.054
White Men 124 (4) 69 (61, 77) 66 1.1 0.44
Hypertension Never Smokers 140 (4) 60 (52, 68) 68 0.9 0.043
Ever Smokers 92 (3) 50 (40, 60) 70 0.7 <0.001
Black Women 74 (2) 66 (56, 77) 81 0.8 0.002
White Women 33 (1) 40 (23, 57) 60 0.7 0.027
Black Men 69 (2) 47 (35, 58) 63 0.7 0.006
White Men 56 (2) 64 (51, 77) 69 0.9 0.55
Obesity Never Smokers 415 (13) 65 (61, 70) 60 1.1 0.033
Ever Smokers 228 (7) 69 (63, 75) 65 1.1 0.20
Black Women 289 (9) 72 (67, 77) 70 1.0 0.47
White Women 134 (4) 62 (54, 70) 52 1.2 0.028
Black Men 130 (4) 60 (51, 68) 60 1.0 1.0
White Men 97 (3) 66 (56, 75) 65 1.0 0.89
*Numbers include weighting when the exact order cannot be determined; see Methods section.
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were not more likely to occur in either order, and neither were
hypertension and diabetes. Obesity was more likely to occur
prior to diabetes and hypertension.
Relationship of Order With Presence of CAC or
CIMT
No pairs of risk factors were associated with a signiﬁcantly
higher prevalence of CAC than expected from participant age,
sex, race, smoking behavior at year 20, and pack-years at year
20. Similarly, no pairs of risk factors were associated with
higher mean CIMTs than expected from participant age, sex,
race, number of risk factors, smoking behavior at year 20, and
pack-years at year 20.
Results for Additional Analysis
Separate analysis by sex, race, and smoking status at baseline
resulted in similar patterns, with some relationships becoming
nonsigniﬁcant because of smaller sample sizes (Tables 5
through 7). Results were also similar when the metabolic
syndrome cut points were used (Tables 8 through 11).
Table 6. Observed Versus Expected Percentage of Being First by Subgroup in Sequences in Participants With at Least Two
Metabolic Risk Factors Accumulated Over 20 Years
Risk Factor Subgroup
Percent Observed With
RF First (95% CI)
Percent Expected
With RF First
Ratio of Observed
to Expected
P Value for
RF First
Diabetes Never Smokers 10 (5, 15) 31 0.3 <0.001
Ever Smokers 10 (4, 15) 33 0.3 <0.001
Black Women 10 (5, 16) 34 0.3 <0.001
White Women 13 (2, 25) 22 0.6 0.30
Black Men 7 (0, 13) 21 0.3 0.012
White Men 10 (2, 18) 26 0.4 0.012
Dyslipidemia Never Smokers 55 (52, 59) 44 1.3 <0.001
Ever Smokers 57 (53, 61) 44 1.3 <0.001
Black Women 52 (48, 56) 41 1.3 <0.001
White Women 65 (60, 70) 47 1.4 <0.001
Black Men 47 (40, 54) 44 1.1 0.45
White Men 58 (53, 63) 45 1.3 <0.001
Hypercholesterolemia Never Smokers 37 (32, 42) 40 0.9 0.23
Ever Smokers 34 (29, 40) 41 0.8 0.032
Black Women 31 (25, 38) 37 0.9 0.15
White Women 31 (24, 38) 43 0.7 0.004
Black Men 48 (39, 56) 40 1.2 0.082
White Men 36 (30, 42) 42 0.9 0.060
Hypertension Never Smokers 18 (14, 21) 41 0.4 <0.001
Ever Smokers 16 (12, 20) 40 0.4 <0.001
Black Women 15 (11, 19) 38 0.4 <0.001
White Women 12 (6, 18) 43 0.3 <0.001
Black Men 20 (14, 26) 42 0.5 <0.001
White Men 20 (14, 26) 41 0.5 <0.001
Obesity Never Smokers 35 (32, 38) 42 0.8 <0.001
Ever Smokers 32 (28, 36) 43 0.8 <0.001
Black Women 40 (36, 44) 41 1.0 0.73
White Women 30 (24, 35) 45 0.7 <0.001
Black Men 38 (32, 45) 44 0.9 0.12
White Men 24 (19, 30) 42 0.6 <0.001
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Table 7. Observed and Expected Occurrence and Order of Pairs of Metabolic Risk Factor Combinations by Subgroup Accumulated
Over 20 Years
Pairwise Combination Subgroup
Number With Combination, Regardless of Temporal Sequence
Percent Occurring in Listed
Sequence
Observed
N (95% CI)
Expected
N
Ratio of
Observed
to Expected P Value
Observed
(95% CI) P Value*
Dyslipidemia and diabetes Never Smokers 114 (94, 134) 303 0.4 <0.001 88 (82, 94) <0.001
Ever Smokers 95 (77, 113) 198 0.5 <0.001 84 (76, 91) <0.001
Black Women 93 (75, 111) 221 0.4 <0.001 84 (77, 92) <0.001
White Women 33 (22, 44) 69 0.5 <0.001 85 (73, 97) <0.001
Black Men 40 (28, 52) 87 0.5 <0.001 90 (81, 99) <0.001
White Men 47 (34, 60) 118 0.4 <0.001 88 (79, 97) <0.001
Dyslipidemia and hypercholesterolemia Never Smokers 317 (285, 349) 512 0.6 <0.001 59 (54, 65) 0.0011
Ever Smokers 258 (230, 286) 334 0.8 <0.001 61 (55, 67) <0.001
Black Women 152 (130, 174) 380 0.4 <0.001 62 (54, 70) 0.005
White Women 129 (108, 150) 185 0.7 <0.001 69 (61, 77) <0.001
Black Men 95 (78, 112) 115 0.8 0.040 46 (36, 56) 0.47
White Men 206 (182, 230) 176 1.2 0.011 60 (54, 67) 0.003
Dyslipidemia and hypertension Never Smokers 368 (334, 402) 63 5.8 <0.001 80 (76, 84) <0.001
Ever Smokers 236 (209, 263) 57 4.1 <0.001 82 (77, 87) <0.001
Black Women 260 (233, 287) 59 4.4 <0.001 84 (79, 88) <0.001
White Women 86 (69, 103) 13 6.7 <0.001 88 (82, 95) <0.001
Black Men 114 (95, 133) 10 11.9 <0.001 78 (70, 86) <0.001
White Men 150 (128, 172) 21 7.0 <0.001 72 (64, 79) <0.001
Dyslipidemia and obesity Never Smokers 638 (598, 678) 262 2.4 <0.001 63 (59, 67) <0.001
Ever Smokers 432 (399, 465) 198 2.2 <0.001 65 (61, 70) <0.001
Black Women 441 (412, 470) 124 3.6 <0.001 59 (54, 63) <0.001
White Women 252 (226, 278) 99 2.5 <0.001 72 (66, 78) <0.001
Black Men 155 (134, 176) 68 2.3 <0.001 55 (47, 63) 0.23
White Men 233 (208, 258) 164 1.4 <0.001 71 (65, 77) <0.001
Hypercholesterolemia and diabetes Never Smokers 65 (49, 81) 22 3.0 <0.001 58 (46, 70) 0.21
Ever Smokers 58 (43, 73) 18 3.1 <0.001 61 (49, 74) 0.12
Black Women 46 (33, 59) 13 3.6 <0.001 50 (36, 64) 1.0000
White Women 18 (10, 26) 3 5.8 <0.001 53 (30, 76) 1.0000
Black Men 25 (15, 35) 4 6.9 <0.001 78 (62, 94) 0.009
White Men 36 (25, 47) 11 3.2 <0.001 62 (47, 78) 0.18
Hypercholesterolemia and hypertension Never Smokers 186 (161, 211) 130 1.4 <0.001 60 (53, 67) 0.008
Ever Smokers 137 (115, 159) 87 1.6 <0.001 65 (57, 73) <0.001
Black Women 110 (91, 129) 77 1.4 <0.001 60 (50, 69) 0.057
White Women 36 (24, 48) 23 1.6 0.007 61 (45, 77) 0.24
Black Men 78 (62, 94) 51 1.5 <0.001 68 (58, 78) 0.002
White Men 103 (84, 122) 64 1.6 <0.001 60 (50, 69) 0.061
Hypercholesterolemia and obesity Never Smokers 268 (238, 298) 220 1.2 <0.001 49 (43, 55) 0.71
Ever Smokers 185 (160, 210) 147 1.3 0.001 50 (43, 57) 1.0
Continued
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Discussion
In this cohort study of 3178 young black and white women
and men, we found that dyslipidemia—primarily low HDL-C
but also including high triglyceride levels—was more likely to
occur ﬁrst in a sequence or in a pair with any other risk factor,
and accumulation of other risk factors was more likely when
dyslipidemia occurred ﬁrst. Hypertension, hypercholesterol-
emia, obesity, and diabetes were less likely than expected to
occur ﬁrst in a sequence, although obesity and hypercholes-
terolemia occurred ﬁrst more often in pairs with hypertension
and diabetes. Hypertension and diabetes were also less likely
to be followed by additional risk factors. These results were
similar when stratiﬁed by sex, race, and smoking status at
baseline and suggest that dyslipidemia screening in early
adulthood may be a good target for early prevention of
cardiovascular risk factor accumulation.
Our results complement previous ﬁndings that dyslipidemia,
speciﬁcally low HDL-C, precedes development of other meta-
bolic risk factors including insulin resistance, hypertension, and
abdominal adiposity.8 Our results are also consistent with other
studies showing lipid abnormalities prior to hypertension and
diabetes. In the Women’s Health Study cohort, the lowest
quintile of HDL-C levels was associated with a 4-fold increase in
incident diabetes compared with the highest quintile, even after
adjustment for other risk factors, whereas the highest quintile
of triglyceride levels was associated with a 3.7-fold increase in
risk compared with the lowest quintile.20 In the same cohort,
low HDL-C was also associated with an increased risk of
incident hypertension after adjustment for other risk factors
(hazard ratio 1.23 for lowest quintile compared with highest), as
were high triglyceride levels (hazard ratio 1.53 for highest
quintile compared with lowest).13 Both studies also suggest
that there may be additional information in the lipoprotein
Table 7. Continued
Pairwise Combination Subgroup
Number With Combination, Regardless of Temporal Sequence
Percent Occurring in Listed
Sequence
Observed
N (95% CI)
Expected
N
Ratio of
Observed
to Expected P Value
Observed
(95% CI) P Value*
Black Women 152 (130, 174) 131 1.2 0.052 46 (38, 54) 0.33
White Women 90 (72, 108) 64 1.4 <0.001 46 (35, 56) 0.46
Black Men 88 (71, 105) 65 1.3 0.003 53 (43, 64) 0.59
White Men 129 (109, 149) 97 1.3 <0.001 52 (44, 61) 0.66
Hypertension and diabetes Never Smokers 101 (82, 120) 36 2.8 <0.001 60 (50, 69) 0.059
Ever Smokers 68 (52, 84) 20 3.3 <0.001 51 (40, 63) 0.90
Black Women 83 (66, 100) 32 2.6 <0.001 54 (43, 64) 0.58
White Women 17 (9, 25) 1 21.4 <0.001 32 (10, 55) 0.23
Black Men 35 (24, 46) 10 3.5 <0.001 63 (47, 79) 0.18
White Men 36 (25, 47) 8 4.4 <0.001 71 (56, 86) 0.020
Obesity and diabetes Never Smokers 123 (102, 144) 62 2.0 <0.001 85 (78, 91) <0.001
Ever Smokers 94 (76, 112) 44 2.1 <0.001 86 (79, 93) <0.001
Black Women 102 (83, 121) 64 1.6 <0.001 82 (74, 89) <0.001
White Women 28 (18, 38) 6 4.9 <0.001 84 (70, 98) <0.001
Black Men 49 (36, 62) 14 3.6 <0.001 91 (83, 99) <0.001
White Men 41 (29, 53) 13 3.1 <0.001 88 (78, 98) <0.001
Obesity and hypertension Never Smokers 381 (347, 415) 254 1.5 <0.001 72 (67, 76) <0.001
Ever Smokers 212 (186, 238) 148 1.4 <0.001 73 (67, 79) <0.001
Black Women 293 (266, 320) 235 1.2 <0.001 75 (70, 80) <0.001
White Women 86 (69, 103) 45 1.9 <0.001 79 (70, 88) <0.001
Black Men 114 (95, 133) 86 1.3 0.002 67 (58, 76) <0.001
White Men 108 (89, 127) 69 1.6 <0.001 64 (55, 73) 0.005
*Compared with a null of 50% (equally likely to be either order).
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particle sizes, with stronger associations in small HDL-C
particles and larger triglyceride-rich particles. Our results
examining all risk factors simultaneously, suggest that HDL-C
and triglycerides are early markers of underlying metabolic
dysfunction leading to additional cardiovascular disease risk
factor accumulation and increased cardiovascular disease risk.
Strengths of our study include the ability to assess
cardiovascular risk factor development in early adulthood,
which is a critical period of risk development. We also had
multiple visits with high-quality repeated measures over
20 years to obtain risk factor information. Risk factors were
directly measured using standardized methods, which reduce
the risk of ascertainment bias. We were not able to calculate
the exact timing of risk factor accrual, leaving residual
ambiguity in our calculations, nor was enough follow-up time
available to assess hard cardiovascular outcomes. We limited
this analysis to dichotomous measures of risk factors and did
not examine reduction in risk factors at subsequent visits, and
we did not examine the effects of risk factor treatment. The
analysis was also limited to those who had complete risk
factor information at the 20-year visit, potentially limiting the
generalizability of the results. In addition, there was no
information on other ethnic groups, such as Asian popula-
tions, which may have different patterns of risk factors
accumulation; however, the study population included black
and white women and men, and stratiﬁed analyses were
similar to the overall results.
Conclusions
Our results suggest that dyslipidemia, primarily due to low
HDL-C but also including elevated triglyceride levels, may
precede development of other established cardiovascular risk
factors. Screening for dyslipidemia and continuing follow-up
of for those young adults who develop dyslipidemia may
provide an opportunity for lifestyle interventions.
Table 8. Rates for ATP III–Based Metabolic Syndrome
Criteria for Cardiovascular Risk Factors (N=3178)*
Indication n
Risk Factor
Identiﬁed by
Criteria, %
Diabetes
Nonfasting glucose >200 mg/dL 22 4
Fasting glucose ≥110 mg/dL 393 79
Diagnosis 53 11
Medication use 28 6
Dyslipidemia
Both high triglycerides
and low HDL
226 11
HDL <40 mg/dL in men
or <50 mg/dL in women
1476 74
Triglycerides ≥150 mg/dL 291 11
Hypercholesterolemia
LDL ≥160 mg/dL 584 71
Total cholesterol ≥240 mg/dL 103 13
Medication use 134 16
Hypertension
Both high diastolic and
systolic
287 23
Systolic blood pressure ≥130 mm Hg 278 22
Diastolic blood pressure ≥85 mm Hg 485 39
Medication use 199 16
Obesity
Both high BMI and WC 655 44
BMI ≥25, kg/m2 559 37
WC >102 cm in men
or >88 cm in women
278 19
BMI indicates body mass index; HDL, high-density lipoprotein; LDL, low-density
lipoprotein; WC, waist circumference.
*Criteria are assessed hierarchically in the order displayed (ie, once assigned to a
criterion, a participant is no longer evaluated for remaining criteria).
Table 9. Accumulation of Subsequent Metabolic Risk Factors When First Risk Factor Is Identiﬁed: ATP III–Based Metabolic
Syndrome Criteria
First Risk Factor
Risk Factor Occurring
First, n (% of Total)*
Observed With Subsequent Risk
Factor Accumulation, % (95% CI)
Expected With Subsequent
Risk Factor Accumulation, %
Ratio of Observed
to Expected
P Value for
Accumulation
DIAB 73 (2) 61 (50 to 73) 78 0.8 <0.001
DYSL 1264 (40) 65 (62 to 68) 62 1.0 0.028
HCL 314 (10) 79 (74 to 83) 77 1.0 0.49
HTN 428 (13) 65 (60 to 69) 73 0.9 <0.001
OBST 580 (18) 75 (72 to 79) 71 1.1 0.020
DIAB indicates diabetes; DYSL, dyslipidemia; HCL, hypercholesterolemia; HTN, hypertension; OBST, obesity.
*Numbers include weighting when the exact order cannot be determined (described in the “Methods” section).
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